-77%

est. 2Y upside i

Healthcare

Predictive analytics and clinical pathways for hospitals

Rank

#3171

Sector

Clinical Decision Support Systems (Healthcare IT)

Est. Liquidity

~4Y

Data Quality

Data: Medium

This opportunity offers moderate upside potential driven by a validated, FDA-cleared AI product with proven clinical outcomes, but it carries significant risk due to intense competition from deeply entrenched EHR incumbents.

Last updated: February 16, 2026

Bull (25%)+200%

FDA clearance and proven outcomes drive rapid adoption, leading to strong revenue growth and a successful Series B/C or strategic acquisition.

Base (25%)+50%

Steady customer acquisition and product development, but market share gains are slow due to incumbent competition.

Bear (50%)-80%

Incumbents stifle growth, leading to limited market penetration and a struggle for further funding.

Est. time to liquidity~3.5 years

Community

Valuation Sentiment

Our model estimates -77% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.